Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Louis

Showing results (171-180 of 290) with videos related to

Pageof 29
Sort By:
The American Journal of Gastroenterology|October 3, 2002
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's diseaseSeverine Vermeire, Edouard Louis, An Carbonez, et al.
Journal of Crohn'S & Colitis|February 13, 2025
A transcriptomic score to classify the inflammation-dysplasia-cancer sequence lesions in inflammatory bowel diseaseAnneline Cremer, Nicolas Rosewick, Maxfield Kelsey, et al.
Epigenetics & Chromatin|September 17, 2021
Identification of tissue-specific and common methylation quantitative trait loci in healthy individuals using MAGARMichael Scherer, Gilles Gasparoni, Souad Rahmouni, et al.
Journal of Crohn'S & Colitis|October 6, 2017
European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel DiseaseGlen Doherty, Konstantinos H Katsanos, Johan Burisch, et al.
Medicina (Kaunas, Lithuania)|February 25, 2023
Role of an Exclusion Diet (Reduced Disaccharides, Saturated Fats, Emulsifiers, Red and Ultraprocessed Meats) in Maintaining the Remission of Chronic Inflammatory Bowel Diseases in AdultsMaria Nitescu, Doina Istratescu, Carmen Monica Preda, et al.
Journal of Crohn'S & Colitis|April 1, 2025
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitisWalter Reinisch, Edward V Loftus, Stefan Schreiber, et al.
Journal of Proteomics|September 15, 2014
Comparison of two FFPE preparation methods using label-free shotgun proteomics: Application to tissues of diverticulitis patientsFlorence Quesada-Calvo, Virginie Bertrand, Rémi Longuespée, et al.
International Journal of Molecular Sciences|August 14, 2025
S100A14 as a Potential Biomarker of the Colorectal Serrated Neoplasia PathwayPierre Adam, Catherine Salée, Florence Quesada Calvo, et al.
United European Gastroenterology Journal|May 7, 2021
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesFerdinando D'Amico, David T Rubin, Paulo Gustavo Kotze, et al.
Journal of Crohn'S & Colitis|June 5, 2024
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn's DiseaseSubrata Ghosh, Brian G Feagan, Rogério Serafim Parra, et al.
Pageof 29

Showing results (171-180 of 290) with videos related to

Sort By:
Pageof 29
The American Journal of Gastroenterology|October 3, 2002
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's diseaseSeverine Vermeire, Edouard Louis, An Carbonez, et al.
Journal of Crohn'S & Colitis|February 13, 2025
A transcriptomic score to classify the inflammation-dysplasia-cancer sequence lesions in inflammatory bowel diseaseAnneline Cremer, Nicolas Rosewick, Maxfield Kelsey, et al.
Epigenetics & Chromatin|September 17, 2021
Identification of tissue-specific and common methylation quantitative trait loci in healthy individuals using MAGARMichael Scherer, Gilles Gasparoni, Souad Rahmouni, et al.
Journal of Crohn'S & Colitis|October 6, 2017
European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel DiseaseGlen Doherty, Konstantinos H Katsanos, Johan Burisch, et al.
Medicina (Kaunas, Lithuania)|February 25, 2023
Role of an Exclusion Diet (Reduced Disaccharides, Saturated Fats, Emulsifiers, Red and Ultraprocessed Meats) in Maintaining the Remission of Chronic Inflammatory Bowel Diseases in AdultsMaria Nitescu, Doina Istratescu, Carmen Monica Preda, et al.
Journal of Crohn'S & Colitis|April 1, 2025
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitisWalter Reinisch, Edward V Loftus, Stefan Schreiber, et al.
Journal of Proteomics|September 15, 2014
Comparison of two FFPE preparation methods using label-free shotgun proteomics: Application to tissues of diverticulitis patientsFlorence Quesada-Calvo, Virginie Bertrand, Rémi Longuespée, et al.
International Journal of Molecular Sciences|August 14, 2025
S100A14 as a Potential Biomarker of the Colorectal Serrated Neoplasia PathwayPierre Adam, Catherine Salée, Florence Quesada Calvo, et al.
United European Gastroenterology Journal|May 7, 2021
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesFerdinando D'Amico, David T Rubin, Paulo Gustavo Kotze, et al.
Journal of Crohn'S & Colitis|June 5, 2024
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn's DiseaseSubrata Ghosh, Brian G Feagan, Rogério Serafim Parra, et al.
Pageof 29